$AEM SGD (AWX.SG)$Regret buying it, Singapore stocks are junk, better buy US stocks.
Translated
3
3
星星之火可以燎原
liked
The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
21
星星之火可以燎原
liked
2023 was a year of small steady gains with no nasty downsides and the occasional pleasant surprise. $Fullerton SGD Cash Fund (SG9999005961.MF)$
PS: Currently, subscribe at least S$500 to any mutual fund via bank account (Subscribe > Click linked bank account > An orange comment about the promotion will show up below the bank account if you qualify) to get a S$2 cash coupon.
Disclaimer: The above is my personal opinion and experience. It is not finan...
PS: Currently, subscribe at least S$500 to any mutual fund via bank account (Subscribe > Click linked bank account > An orange comment about the promotion will show up below the bank account if you qualify) to get a S$2 cash coupon.
Disclaimer: The above is my personal opinion and experience. It is not finan...
29
11
1